Literature DB >> 172972

Defective interfering (di) particles of poliovirus.

C N Cole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172972

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN: 0079-645X


× No keyword cloud information.
  14 in total

1.  The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.

Authors:  K L McKnight; S M Lemon
Journal:  RNA       Date:  1998-12       Impact factor: 4.942

2.  Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA.

Authors:  K L McKnight; S M Lemon
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  2A protease is not a prerequisite for poliovirus replication.

Authors:  Hiroko Igarashi; Yasuko Yoshino; Miwako Miyazawa; Hitoshi Horie; Seii Ohka; Akio Nomoto
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

4.  Bovine viral diarrhea virus: characterization of a cytopathogenic defective interfering particle with two internal deletions.

Authors:  H Kupfermann; H J Thiel; E J Dubovi; G Meyers
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants.

Authors:  C J Gauntt; M D Trousdale; J C Lee; R E Paque
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

Review 6.  Picornaviral structure and assembly.

Authors:  J R Putnak; B A Phillips
Journal:  Microbiol Rev       Date:  1981-06

7.  Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl.

Authors:  S M Lemon; R W Jansen; J E Newbold
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

8.  Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.

Authors:  W S Choi; R Pal-Ghosh; C D Morrow
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.

Authors:  D C Porter; D C Ansardi; W S Choi; C D Morrow
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.